D-0398-2021 Class I Terminated

Recalled by Acella Pharmaceuticals, LLC — Alpharetta, GA

FDA drug recall D-0398-2021 was initiated by Acella Pharmaceuticals, LLC on Apr 29, 2021 and is designated Class I. Reason for recall: Subpotent Drug The recall status is terminated (terminated Mar 13, 2024). Affected quantity: 79,344 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 2, 2021
Initiation Date
Apr 29, 2021
Termination Date
Mar 13, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
79,344 bottles

Product description

NP Thyroid 90 Thyroid Tablets, USP 1&1/2 grain (90 mg) 100-count bottles, Rx only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-331-01

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide within the United States including Puerto Rico

Code information

Lots: M331J19-10A, M331J19-11, M331J19-2A, M331J19-6A, Exp. 08/31/2021, M331K19-1, M331K19-2, M331K19-6, Exp. 09/30/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0398-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0398-2021. Report a data issue: hello@regdatalab.com.